Sign inJoin waitlistJoin the waitlist

Michael J. Satlin

Clinical Director of the Transplantation-Oncology Infectious Diseases Program · Weill Cornell

Credentials: · · ·

History

Transplantation-Oncology Infectious Diseases Program · Weill Cornell
Present
Weill Cornell Medical College
Present
Weill Cornell Medical College
Present

Research

Infectious Diseases Society of America 2024 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections
Clinical Infectious Diseases · 2024 · 972 citations
COVID-19 in solid organ transplant recipients: Initial report from the US epicenter
American Journal of Transplantation · 2020 · 627 citations
Impact of Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load on Risk of Intubation and Mortality Among Hospitalized Patients With Coronavirus Disease 2019
Clinical Infectious Diseases · 2021 · Last of 9 authors · Corresponding · 311 citations

Lars Westblade
42 papers
Thomas Walsh
31 papers
Rosemary Soave
20 papers
David van Duin
16 papers
Robert Bonomo
16 papers
Tsiporah Shore
16 papers
Cesar Arias
13 papers
Vance Fowler
13 papers
Yohei Doi
13 papers
John Lee
12 papers · 1 as a fellow
Koen van Besien
11 papers
Darshana Dadhania
10 papers

Grants

Screening for Fluoroquinolone-Resistant Viridans Group Streptococci to Individualize Infection Prevention Strategies in Neutropenic Patients
National Institute of Allergy and Infectious Diseases · R21
Contact PI · $466.1K · Weill Medical Coll of Cornell Univ
2024–2027
Screening for Resistant Enteric Bacteria to Personalize Infection Prevention Strategies in Neutropenic Patients
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $2.1M · Weill Medical Coll of Cornell Univ
2020–2025
Predicting Infections in Neutropenic Hosts Receiving Fluoroquinolone Prophylaxis
National Institute of Allergy and Infectious Diseases · R03
Contact PI · $169.5K · Weill Medical Coll of Cornell Univ
2020–2023
Rapid Identification of Neutropenic Patients at High Risk of CRE Bacteremia
National Institute of Allergy and Infectious Diseases · K23
Contact PI · $925.2K · Weill Medical Coll of Cornell Univ
2014–2020

Clinical trials

Master Protocol for Evaluating Multiple Infection Diagnostics for Ciprofloxacin-Resistant Neisseria Gonorrhoeae
Principal investigator · Completed
Duke University
2025–2026
Screening for Colonization With Resistant Enterobacterales in Neutropenic Patients With Hematologic Malignancies
Principal investigator · Completed
Duke University
2021–2022